Benefit-and-cost analysis of medical interventions

the case of cimetidine and peptic ulcer disease by Harvey V. Fineberg

Publisher: Congress of the U.S., Office of Technology Assessment, Publisher: For sale by the Supt. of Docs., U.S. G.P.O. in Washington, D.C

Written in English
Published: Pages: 64 Downloads: 209
Share This

Subjects:

  • Cimetidine -- Cost effectiveness.,
  • Peptic ulcer -- United States.,
  • Medical technology -- Cost effectiveness.,
  • Medical instruments and apparatus -- Cost effectiveness.

Edition Notes

StatementHarvey V. Fineberg and Laurie A. Pearlman.
SeriesThe Implications of cost-effectiveness analysis of medical technology. Background paper #2, Case studies of medical technologies -- case study #1
ContributionsPearlman, Laurie A., United States. Congress. Office of Technology Assessment.
The Physical Object
Paginationviii, 64 p. :
Number of Pages64
ID Numbers
Open LibraryOL22386654M

Along with the many advantages of a cost benefit analysis, there are many arguments against using a cost benefit analysis as a decision-making tool. In addition to being inaccurate, incomplete, and somewhat simplistic, other disadvantages of a cost benefit analysis include being too subjective, using an unrealistic discount rate necessary for accurate present value calculations, and potential.   Context. —The Agency for Health Care Policy and Research (AHCPR) published the Smoking Cessation: Clinical Practice Guideline in Based on the results of meta-analyses and expert opinion, the guideline identifies efficacious interventions for primary care clinicians and smoking cessation specialty by:   Where. t = the unit of analysis (usually a year). i = the discount rate (%). R t = the value of the public benefits—costs (£). N = lifetime of the intervention in units of analysis (number of years). NPV is the discounted value of a stream of future costs or benefits. It is used to describe the difference between the present value of a stream of costs and a stream of : Lee Robertson, Chris Skelly, David Phillips. University of Minnesota, introduced the concepts of cost–benefit and cost-effectiveness analyses.8 Bootman et al.9 also published an early pharmacy research article in in which cost–benefit analysis was used to evaluate the outcomes of individualizing aminoglycoside dosages in File Size: KB.

Cost-effective analysis is imperative because it assists in finding interventions that are relatively inexpensive, yet have the ability to significantly reduce poverty and disease. For example, more than 1 million children die from diarrhea every year, and oral rehydration therapy has been found to alleviate some of the harmful effects. medical interventions, arguing that the use of a new technique or technology can be justified if it has at least as favorable a cost per QALY as generally accepted interventions. Despite the widespread use of CE analysis, we are unaware of any publishedFile Size: 2MB.   In a climate of economic uncertainty, cost effectiveness analysis is a potentially important tool for making choices about health care interventions. Methods for such analyses are well established, but the results need to be interpreted carefully and are subject to bias. Making decisions based on results of cost-effectiveness analyses can involve setting thresholds, but for individual patients Cited by:   Future cost–benefit analysis can take into account cost savings of parents (from fewer hospital visits or other medical issues linked to children's health); cost savings to the education system (from starting school on time and ready to learn, resulting in lower repetition and dropout rates in kacchi [pre‐primary] and primary classes); cost Cited by:

  The base-case analysis was conducted in 5 steps: (1) a retrospective estimation of the intervention cost, (2) an estimation of the number of students prevented from becoming established smokers by age 26 years, (3) an estimation of the number of LYs saved and QALYs saved by the intervention, (4) an estimation of the lifetime medical care costs Cited by:   Benefit-cost analysis (BCA) provides a framework for systematically assessing the efficiency of public policies. Increasingly, BCA is being applied to social policies, ranging from preschool interventions to prison reentry by:   Cost Benefit vs Cost Effectiveness Cost benefit analysis and cost effective analysis are both tools used for decision making and help in evaluating a project/investment/course of action in terms of either their feasibility and profitability or value and effectiveness.

Benefit-and-cost analysis of medical interventions by Harvey V. Fineberg Download PDF EPUB FB2

Get this from a library. Benefit-and-cost analysis of medical interventions: the case of cimetidine and peptic ulcer disease. [Harvey V Fineberg; Laurie A Pearlman; United States.

Congress. Office of Technology Assessment.]. with a critique of one major analysis of cimeti-dine’s costs and benefits and some suggestions for further research.

The Benefit-and-Cost Model for Medical Interventions The benefit-and-cost model stresses that an evaluation of medical technology must apply to an identifiable patient population and a.

COST–BENEFIT ANALYSIS. Cost–benefit analysis compares the dollars expended for an intervention with the dollars gained from the intervention.

For example, let us assume that a VEGF inhibitor treatment for neovascular AMD has direct medical costs of $10 /year. Anthony E. Boardman, in International Encyclopedia of the Social & Behavioral Sciences (Second Edition), The purpose of cost–benefit analysis (CBA) is to make better-informed, more consistent policy decisions (see Policy Analysis: Evidence-Based Policy Making).CBA is a method for assessing the economic efficiency of proposed public policies through the systematic prediction and.

Benefit-and-Cost Analysis of Medical Interventions: The Case of Cimetidine and Peptic Ulcer Disease Harvey V. Fineberg, M. D., Ph.D. Associate Professor and Laurie A. Pearlman, A.B.

Research Analyst Harvard School of Public Health Boston, Mass. AUTHORS’ ACKNOWLEDGMENTS A number of people aided us at various stages in the preparation of this. Benefit-cost analysis allows you to consider all costs and benefits over time, even those beyond the length of the intervention.

As is often the case with preventive interventions, the costs of the intervention occur in the immediate future and benefits occur in the distant Size: KB. Benefit-And-Cost Analysis of Medical Interventions: The Case of Cimetidine and Peptic Ulcer Disease (), by United States Congress Office of Technology Assessment (PDF files at Princeton) The Implications of Cost-Effectiveness Analysis of Medical Technology (), by United States Congress Office of Technology Assessment.

page images at. Download Digestive Disease Interventions ebook PDF or Read Online books in PDF, Click Download or Read Online button to Digestive Disease Interventions book pdf for free now. Digestive Disease Interventions. Author: Baljendra S.

Kapoor ISBN: Medical Benefit And Cost Analysis Of Medical Interventions The Benefit-and-cost analysis of medical interventions book Of. MEDICAL CARE NovemberVol. XVIII, No. 11 Original Articles Cost-Benefit and Cost-Effectiveness Analysis in Health Care Growth and Composition of the Literature KENNETH E.

WARNER, PH.D.,* AND REBECCA C. HUTTON, M.H.S.A., M.A.A.E.f Concern about the escalating costs of health services is reflected in the rapid. Cost Benefit or Benefit Cost Analysis.

Decem by Fahad Usmani. It Benefit-and-cost analysis of medical interventions book rare for an organization to have unlimited resources; they must choose the best of all the opportunities available to them.

One of the ways organizations make decisions is by using cost-benefit analysis. TRB’s Transit Cooperative Research Program (TCRP) Web-Only Document Cost-Benefit Analysis of Providing Non-Emergency Medical Transportation (NEMT) examines the relative costs and benefits of providing transportation to non-emergency medical care for individuals who miss or delay healthcare appointments because of transportation issues.

A cost benefit analysis (also known as a benefit cost analysis) is a process by which organizations can analyze decisions, systems or projects, or determine a value for intangibles. The model is built by identifying the benefits of an action as well as the associated costs.

Introduction. Health care costs continue to rise. An important concern for patients, clinicians, and policy makers is whether it is possible to control costs while maintaining the quality of health care services [].The use of information and communication technology (ICT) in health care (eHealth) is proposed as a useful tool to increase efficiency, improve access, and improve the quality Cited by:   The results of clinical trials are often expressed in relative terms - for example, a particular treatment reduces the risk of an adverse outcome by 40%.

Yet knowing that the treatment reduces the risk of such an outcome from 5% to 3% (an absolute reduction of 2%) may be more useful clinically.1 The effects of antiplatelet treatment are a case in point.

The meta-analysis of randomised Cited by: Correctional Intervention Programs and Cost-Benefit Analysis Article in Criminal Justice and Behavior 27(1) February with 56 Reads How we measure 'reads'. analysis of the economics of bridges in b y the French engineer and economist Jules Dupuit. 44 M.

Svensson & L. Hultkrantz / Nordic Jou rnal of Health Economics, Vol. 5 (), No. 2, pp. 41 - Three speakers at the workshop provided compelling examples of the use of benefit-cost analyses to inform policy decisions.

Though the examples are quite different, they reveal many of the issues that arise in gathering, analyzing, and disseminating benefit and cost data.

They also demonstrate both the opportunities and the challenges of creating greater standardization in the : Youth Board on Children, Families. the allocation of resources for possible effective interventions for critical diseases such as HIV (Holtgrave & Pinkerton, ; Pinkerton & Holtgrave, ).

With these pressures, the development and use of cost-benefit and cost-effectiveness methodologies in the health and. Fineberg HV, Pearlman LA. Benefit and cost analysis of medical interventions: the case of cimetidine and peptic ulcer disease. Case Study #11 in Background Paper #2 in Case Studies of Medical Technologies.

Office of Technology Assessment, U.S. Congress. Washington, D.C.: U.S. Government Printing Office, $13, with a % discount rate and constant medical cost growth. Other states of the world were simulated as well, including a world where medical costs flatten over time and a world where medical costs increase over time.

A sensitivity analysis was also conductedFile Size: 2MB. Cost-effectiveness analysis is sometimes called cost-utility analysis. It is different to cost-benefit analysis. In cost-benefit analysis, the outcome is described in monetary terms. For example, if the outcome is preventing one case of HIV you could assign a monetary value to this by adding up the average healthcare costs for an HIV patient.

Cost Benefit Analysis Involves a Particular Study Area The impacts of a project are defined for a particular study area, be it a city, region, state, nation or the world. In the above example concerning cotton the impact of the project might be zero for the nation but still be a positive amount for Arizona.

Cost-benefit and cost-effectiveness Economic benefit was compared to intervention cost in 2 21, 23 studies of EHR-based CDSSs and 1 32, 33 study of both EHR- and registry-based CDSSs (Table 4).

The same time horizons were used for benefits and cost in these by: 7. The aim of the study is to reduce the high prevalence of tooth decay in children in a remote, rural Indigenous community in Australia, by application of a single annual dental preventive intervention.

The study seeks to (1) assess the effectiveness of an annual oral health preventive intervention in slowing the incidence of dental caries in children in this community, (2) identify the Cited by: 7. A comprehensive meta-analysis of 91 medical cost offset studies in medical populations published between and concluded that 90% of the studies reported some degree of decreased medical utilization following psychological intervention.

The estimated savings were $1, USD per person over all of these by: Fineberg HV () Benefit-and-cost analysis of medical interventions: The case if Cimetidine and peptic ulcer disease; Office of Technology Assessment Washington D.C., background paper, Case Study No. 11, (U.S. Government Printing Office) Google ScholarCited by: Regional and.

Urban Policy. December Guide to Cost-Benefit Analysis of Investment Projects. Economic appraisal tool. for Cohesion Policy Cost–benefit analysis (CBA), sometimes also called benefit–cost analysis or benefit costs analysis, is a systematic approach to estimating the strengths and weaknesses of alternatives used to determine options which provide the best approach to achieving benefits while preserving savings (for example, in transactions, activities, and functional business requirements).

These included a variety of acute medical conditions. 2 In view of the Quinine-Related Hypoglycemia To the Editor: White et al. (July 14 issue)* report that quinine can cause. interventions are considered alongside their effects.

Cost-effectiveness analysis is a straightforward but under-utilised tool for determining which of two or more inter-ventions provides a (non-pecuniary) unit of effect at least cost. This paper reviews the framework and methods of cost-effectiveness analysis, emphasising education. Open Library is an initiative of the Internet Archive, a (c)(3) non-profit, building a digital library of Internet sites and other cultural artifacts in digital projects include the Wayback Machine, and Where: t = the time of the cash flow.

i = the opportunity cost of capital. R t = the net cash flow = Cash Inflow – Cash Outflow (at time t). N = total number of periods NPV is based on inflation and any lost return on investment: Inflation dictates that the current purchasing power of a dollar will be less 12 months from example, the value of one dollar today will be worth only Cost-effectiveness analysis is a way to examine both the costs and health outcomes of one or more interventions.

It compares an intervention to another intervention (or the status quo) by estimating how much it costs to gain a unit of a health outcome, like a life year gained or a death prevented.